This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Beckman Research Institute, City of Hope, City of Hope, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 692 
1 out of 9 
1 out of 3,696 
Years Active: 2026
Title: Jianjun Chen: Innovator in Cancer Treatment
Introduction
Jianjun Chen is a notable inventor based in Temple City, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of various inhibitors.
Latest Patents
Jianjun Chen holds 3 patents, with his latest inventions focusing on IGF2BP2 inhibitors and METTL16 inhibitors. The disclosure of these patents provides methods for treating cancers that overexpress METTL16, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Jianjun has worked with esteemed organizations such as City of Hope and the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in developing therapeutic strategies for cancer treatment.
Collaborations
Jianjun has collaborated with notable colleagues, including Xiaolan Deng and Li Han, contributing to a rich exchange of ideas and advancements in their field.
Conclusion
Jianjun Chen's innovative work in developing cancer treatment inhibitors highlights his dedication to improving healthcare outcomes. His contributions continue to influence the landscape of medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile